Number of animals
| WT (N) | KO (N) | |
|---|---|---|
| Long-term studies | ||
| SCI | 21 | 24 |
| BMS | 21 | 24 |
| Grid-walk | 13 | 8 |
| White matter sparing | 11 | 8 |
| Acute studies | ||
| Uninjured | 7 | 7 |
| SCI | 19 | 19 |
| Immunoblotting | 8 | 8 |
| Flow cytometry | 18 | 18 |
| Vehicle (N) | Diclofenac (N) | |
| Long-term studies | ||
| SCI (WT) | 75 | 122 |
| SCI (KO) | 6 | 5 |
| BMS | 79 | 109 |
| Grid walk | 4 | 11 |
| White matter sparing | 14 | 28 |
| Mortality (single dose) | 2 | 1 |
| Mortality (two doses) | N/A | 8 |
| Mortality (three doses) | N/A | 9 |
| Acute studies | ||
| In vitro | 21 (pooled) | |
| Uninjured | 18 | 18 |
| SCI | 29 | 107 |
| Flow cytometry | 25 | 25 |
| ELISA | 17 | 95 |
| Immunoblotting | 5 | 5 |